Fierce Pharma

JULY 13, 2023

With the multiple sclerosis market growing rapidly—from $18.9 billion in 2020 to a projec | A phase 3 study has shown that a new, subcutaneous version of Roche's Ocrevus has proven to be non-inferior to the current infused treatment as measured by the level of drug in the blood, 12 weeks after administration. An approval for the injected version would allow patients to receive treatment in 10 minutes as opposed to four hours, every six months.

Marketing 226

Marketing Patients 226

PM360

JULY 13, 2023

PM360 asked six CEOs at companies developing cancer treatments to provide an update on the latest and most exciting breakthroughs in their respective areas of expertise including: antibody-drug conjugates, CAR-T immunotherapies, cytokine-based therapy, mRNA/epigenetics, precision immuno-oncology, and small molecules. Dan O’Connor Most Exciting Development Within Your Area of Cancer Treatments The most exciting development within the antibody-drug conjugate (ADC) space is site-specific conjugatio

Patients 98

Patients Engineering Side effects Leads 98

Fierce Pharma

JULY 13, 2023

After a full FDA approval last week triggered Medicare coverage of Eisai and Biogen’s Leqembi, doctors are still trying to work out the logistics of testing and reimbursement. | After a full FDA approval last week triggered Medicare coverage of Eisai and Biogen’s Leqembi, doctors are still working out the logistics of testing and reimbursement. But at least two experts remain positive about the drug’s efficacy and safety profile.

Doctors 213

Doctors Safety FDA 213

PM360

JULY 13, 2023

“Drugs don’t work in patients who don’t take them,” C. Everett Koop, MD, U.S. Surgeon General, said in 1985. Novartis’ analysis of claims data from Nov. 2020 to Oct. 2021 revealed that roughly one in four prescriptions were never filled. 1 In addition, of patients who began therapy, more than 70% were no longer on their prescribed medication after 12 months. 1 Patients may discontinue if they cannot afford their out-of-pocket costs even with insurance coverage due to side effects or lack of perc

Patients 98

Patients Side effects Insurance Medical 98

Advertisement

Distribution

Fierce Pharma

JULY 13, 2023

CureVac is adding fuel to its COVID-19 vaccine patent fire by asserting more claims against Pfizer and BioNTech in both its U.S. and German cases. | CureVac is adding more fuel to the fire in its COVID-19 patent cases against Pfizer and fellow German mRNA maker BioNTech, adding a tenth claim in its U.S. dispute and three to its suit in Germany.

197

197

Copyright Clearance Center

JULY 13, 2023

After introducing The State of Scholarly Metadata: 2023 interactive report this April at the London Book Fair, we have continued to facilitate conversations about the importance of quality metadata with those in scholarly communications.

98

98

Pharma Marketing Network

JULY 13, 2023

When it comes to marketing your pharma business on Facebook, you may be wondering whether you should boost a post or create an ad. Both have their own advantages and disadvantages, so it’s important to choose the right option for your needs. Boosting a post is a quick and easy way to get more exposure for your content. When you boost a post, you’re essentially paying to increase its reach and visibility.

Pharma 98

Pharma Networking Consulting Marketing 98

Fierce Pharma

JULY 13, 2023

With nonprescription nod for Perrigo's Opill, the age of the over-the-counter birth control pill arrives in the US fkansteiner Thu, 07/13/2023 - 09:48

213

213

PM360

JULY 13, 2023

A 2019 study published in the Journal of Medical Internet Research mHealth and uHealth found 704 apps related to medication adherence available from Apple (443) and Android (261). And that was four years ago! I imagine anyone willing to count the apps available today would find even more. And yet, the issue of medication nonadherence persists to this day—but it is clearly not for a lack of trying.

Medical 98

Medical Specialization Pharma Patients 98

Fierce Pharma

JULY 13, 2023

Almost exactly one year after GSK’s consumer healthcare business spun out on its own as Haleon, the company is reportedly looking to save costs with sweeping layoffs across the board. | One year after spinning out from GSK, consumer health business Haleon is looking to cut hundreds of jobs in the U.K. and potentially thousands worldwide as part of an effort to save 300 million pounds over three years, The Guardian reports.

Healthcare 177

Healthcare Healthcare 177

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

PM360

JULY 13, 2023

During the COVID-19 pandemic, we saw healthcare organizations spend and scramble to implement numerous virtual care point solutions. The global healthcare IT market was valued at $280.3 billion in 2020 and is expected to reach $381.7 billion by 2025, growing at a compound annual growth rate of 6.7%. 1 This increased technology spending has led to industry fragmentation, creating siloed data—which can leave providers with an incomplete picture of a patient’s health record—and an often-cumbersome

Healthcare 98

Healthcare Healthcare Consulting Healthcare Provider 98

Fierce Pharma

JULY 13, 2023

In this episode of "The Top Line," we talk with Dr Reanne Moore, an associate professor of psychiatry at the University of California San Diego, about the state of digital phenotyping. | This week on "The Top Line," we discuss the state of digital phenotyping, plus the vaccine patent lawsuits, the smallest insulin pump, and the rest of the week's headlines.

174

174

PM360

JULY 13, 2023

PM360 asked experts in helping patients stay on their prescribed therapies about where the industry could make the biggest improvements and how to better detect potential barriers. Specifically, we asked them: What is the biggest area where the industry could stand to improve its approach to boosting adherence? Why is the industry currently doing poorly in this area?

Medical 98

Medical Patients Education Transportation 98

Pharma Marketing Network

JULY 13, 2023

The pharmaceutical industry is a highly regulated industry, and as such, marketing strategies must be carefully planned and executed. However, this does not mean that out-of-the-box marketing is not possible or effective. In fact, in some cases, out-of-the-box marketing can be the most effective way to reach target audiences and achieve marketing goals.

Marketing 98

Marketing Pharma Media Pharmaceutical 98

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

PM360

JULY 13, 2023

The media planning landscape in the pharmaceutical industry has significantly changed over the last few decades, especially since the pandemic. Pharmaceutical companies are faced with the ongoing challenge of maximizing efficiency and ROI while maintaining a strong focus on quality research and development. Although marketers have many options to manage their media planning and buying, the right model and mix are key for the ongoing success of brand marketing.

Media 98

Media Pharma Marketing Digital Media 98

Pharma Marketing Network

JULY 13, 2023

Your website is your online storefront, so it’s important to choose the best web development company to create it. In the pharmaceutical industry, where trust and credibility are essential, it’s especially important to choose a web development company that understands the specific needs of your business. Here are some factors to consider when choosing a web development company for the pharmaceutical industry: ● Experience in the pharmaceutical industry: Make sure the company you choo

Pharmaceutical 97

Pharmaceutical Consulting Networking Pharma 97

PM360

JULY 13, 2023

“People adhere to medicines at a scale that should bewilder everyone in healthcare,” exclaims Grace Lomax, Clinical Director of Patient Connect , part of Clarivate. If you work in this industry and are not yet bewildered by the issue of medication nonadherence, allow Grace Lomax to put things into perspective. “Only 8% of people taking ramipril—one of the most highly prescribed cardiovascular drugs in the world—are fully adherent over 12 months.

Patients 98

Patients Education Medical Side effects 98

European Pharmaceutical Review

JULY 13, 2023

In EPR’s Future of Bio/Pharmaceutical Analysis online summit last month, Lonza’s Associate Director of R&D discussed the benefits and challenges of using process analytical technology (PAT) in biologics manufacturing. The CDMO’s Carrie Mason shared that PAT, “takes a little bit more time and more effort and more capital to set up in the beginning, but once you get it up and running it’s very continuous and it should continue to provide results for a long time”.

Manufacturing 94

Manufacturing Recruitment Engineering Distribution 94

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

MedCity News

JULY 13, 2023

A coalition of nearly 2,000 employers, patient advocates, pharmacies, providers and businesses sent a letter to Congress on Wednesday urging the passage of legislation that would reform PBM practices.

Patients 91

Patients Prescription 91

Pharmaceutical Commerce

JULY 13, 2023

Walmart has opened 70 Specialty Pharmacies of the Community locations across the U.S. in June, and is expected to open 80 more in 11 states by the end of the year.

98

98

MedCity News

JULY 13, 2023

The healthcare industry must understand and act on this bigger picture of evidence-based, data-driven, and technology-enabled solutions for medical equipment management to keep clinical service lines operating effectively and reliably.

Healthcare 89

Healthcare Healthcare Management Medical 89

PM360

JULY 13, 2023

PM360 asked for companies to send in their latest and best ways to improve adherence. Here are twelve of the best examples of programs, strategies, solutions, technology, and more that companies have developed or are using to keep patients on their prescribed therapies. BrightInsight PSP+ Companion App BrightInsight Jamie Burgess, Senior Vice President, Marketing jamie.burgess@brightinsight.com Patient support programs (PSPs) are a proven way to smooth the patient journey, speed time to fill, an

Education 89

Education Medical Media Patients 89

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

MedCity News

JULY 13, 2023

FDA approval of Opill makes it the first oral contraceptive that may be used without a prescription. Clinicians say over-the-counter availability will lower barriers to access to a key component of reproductive healthcare.

FDA 88

FDA Prescription Healthcare Healthcare 88

European Pharmaceutical Review

JULY 13, 2023

In many European countries physicians can now prescribe medical cannabis for an array of chronic health conditions, including chronic pain, mental health disorders and neurological conditions. 1,2 Yet the pace of adoption in Europe has notably lagged countries such as Canada, Australia and the US. 1 In many countries, medical cannabis is only utilised as a therapy when licensed medications have proven ineffective. 1,2 Moreover, except for countries such as Czechia, Denmark and Germany, the cost

Medical 87

Medical Food and Drug Administration Pharmacology Medicine 87

MedCity News

JULY 13, 2023

To prevent the proliferation of data security incidents in the healthcare industry, providers must examine their use of legacy systems as well as their reliance on third parties, according to a new report. It pointed out that most providers fail to probe their third-party partners’ cybersecurity measures, and many continue to use legacy systems that are no longer supported by vendors or are hard to patch and update.

Healthcare 85

Healthcare Healthcare 85

Pharmaceutical Technology

JULY 13, 2023

NVIDIA signed an investment and collaboration agreement with Recursion to create AI models to accelerate drug discovery.

98

98

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

MedCity News

JULY 13, 2023

Affect Therapeutics’ $16 million Series A funding round was led by ARTIS Ventures and included participation from AlleyCorp, CityLight, LifeArc Ventures, Samsung Next and What If Ventures. In total, Affect Therapeutics has raised about $26 million, said Kristin Muhlner, co-founder and CEO of the company.

85

85

PharmaTimes

JULY 13, 2023

Results are from company’s phase 2 head and neck cancer trial with lead NOX inhibitor candidate - News - PharmaTimes

Leads 86

Leads 86

MedCity News

JULY 13, 2023

Local governments around the country are using Covid relief funds to eliminate medical debt for their communities. But Covid relief funds are not a long-term solution. Provide training to your teams on how to communicate with patients to make it clear that financial assistance is available and encourage those who may qualify to apply.

Medical 78

Medical Government Training Patients 78

European Pharmaceutical Review

JULY 13, 2023

Genentech’s Phase III OCARINA II clinical trial evaluating Ocrevus ® (ocrelizumab) as a twice a year 10-minute subcutaneous injection has been shown to be non-inferior to administration by intravenous infusion (IV) in relapsing MS (RMS) or primary progressive MS (PPMS). Humanised monoclonal antibody (mAb) Ocrevus is the first and only therapy approved for both RMS and PPMS.

Safety 63

Safety Medical Leads Pharmaceutical 63

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management